Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status

Respiratory Medicine

Volumn 107, Issue 7, 2013, Pages 1053-1060

  Miravitlles, Marc ^a,b   Soriano, Joan B ^c   Ancochea, Julio ^b,d   Muñoz, Luis ^e   Duran Tauleria, Enric ^f   Sánchez, Guadalupe ^g   Sobradillo, Víctor ^h   García Río, Francisco ⁱ  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Laboratory of Microbial Pathogenesis   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^e HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^f INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^g GLAXOSMITHKLINE   (Spain)

^h HOSPITAL DE CRUCES   (Spain)

ⁱ UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Asthma; COPD; Phenotypes; Physical activity; Quality of life

Indexed keywords

ALPHA 1 ANTITRYPSIN; C REACTIVE PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ASTHMA; ASTHMATIC STATE; BLOOD SAMPLING; BODY MASS; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DAILY LIFE ACTIVITY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH STATUS; HUMAN; LEISURE; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; SELF CARE; SMOKING; SPAIN; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SYMPTOMATOLOGY; WHEEZING;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; ASTHMA; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; PHENOTYPE; PSYCHOMETRICS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SPAIN; VITAL CAPACITY;

EID: 84878927718     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.03.007     Document Type: Article

References (42)

1. A.J. Wardlaw, M. Silverman, R. Siva, I.D. Pavord, and R. Green Multi-dimensional phenotyping: towards a new taxonomy for airway disease Clin Exp Allergy 35 2005 1254 1262
2. P.G. Gibson, and J.L. Simpson The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 64 2009 728 735
3. J.B. Soriano, K.J. Davis, B. Coleman, G. Visick, D. Mannino, and N.B. Pride The proportional Venn diagram of obstructive lung disease Chest 124 2003 474 481
4. F.T. Shaya, D. Dongyi, M.O. Akazawa, C.M. Blanchette, J. Wang, and D.W. Mapel S.M. Scharf Burden of concomitant asthma and COPD in a Medicaid population Chest 134 2008 14 19 (Pubitemid 352008758)
5. E. Díaz-Guzman, M. Khosravi, and D.M. Mannino Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population COPD 8 2011 400 407
6. M. Hardin, E.K. Silverman, R.G. Barr, N.H. Hansel, and Make BJ. Schroeder for the COPDGene Investigators The clinical features of overlap between COPD and asthma Respir Res 12 2011 127
7. M.K. Han, A. Agustí, P.M. Calverley, B.R. Celli, G. Criner, and J.L. Curtis Chronic obstructive pulmonary disease phenotypes. The future of COPD Am J Respir Crit Care Med 182 2010 598 604
8. M. Miravitlles, M. Calle, and J.J. Soler-Cataluña Clinical phenotypes of COPD. Identification, definition and implications for guidelines Arch Bronconeumol 48 2012 86 98
9. J. Ancochea, C. Badiola, E. Duran, F. García-Río, M. Miravitlles, L. Muñoz, V. Sobradillo, and J. Soriano Estudio EPI-SCAN: resumen del protocolo de un estudio para estimar la prevalencia de EPOC en personas de 40 a 80 años de edad en España Arch Bronconeumol 45 2009 41 47
10. M. Miravitlles, J.B. Soriano, F. García-Río, L. Muñoz, E. Duran-Taulería, and G. Sánchez Prevalence of COPD in Spain: Impact of undiagnosed COPD on quality of life and daily life activities Thorax 64 2009 863 868
11. J.C. Bestall, E.A. Paul, R. Garrod, R. Garnham, P.W. Jones, and J.A. Wedzicha Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease Thorax 54 1999 581 586 (Pubitemid 29296676)
12. A. Minette Questionnaire of the European Community for Coal and Steel (ECSC) on respiratory symptoms. 1987-updating of the 1962 and 1967 questionnaires for studying chronic bronchitis and emphysema Eur Respir J 2 1989 165 177 (Pubitemid 19068714)
13. J. Vilaró, E. Gimeno, N. Sánchez Férez, C. Hernanco, I. Díaz, and M. Ferrero Actividades de la vida diaria en pacientes con enfermedad pulmonar obstructiva crónica: validación de la traducción española y análisis comparativo de 2 cuestionarios Med Clin (Barc) 129 2007 326 332 (Pubitemid 47581554)
14. X. Badia, M. Roset, S. Montserrat, M. Herdman, and A. Segura La versión española del EUROQoL: descripción y aplicaciones Med Clin (Barc) 112 suppl. 1 1999 79 85
15. M. Ferrer, J. Alonso, L. Prieto, V. Plaza, E. Monsó, and R. Marrades Validity and reliability of the St. George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example Eur Respir J 9 1996 1160 1166 (Pubitemid 26231729)
16. F. García-Río, M. Miravitlles, J.B. Soriano, L. Muñoz, E. Duran-Taulería, and G. Sánchez Systemic inflammation in chronic obstructive pulmonary disease: a population-based study Respir Res 11 2010 63
17. M. Miravitlles, I. Andreu, Y. Romero, S. Sitjar, A. Altés, and E. Anton Difficulties in differential diagnosis of COPD and asthma in primary care Br J Gen Pract 62 2012 e68 e75
18. B. Piras, and M. Miravitlles The overlap phenotype: the (missing) link between asthma and COPD Multidiscip Respir Med 7 2012 8
19. L.P. Boulet, C. Lemiere, F. Archambault, G. Carrier, M.C. Descary, and F. Deschesnes Smoking and asthma: clinical and radiological features, lung function, and airway inflammation Chest 129 2006 661 668
20. M. Decramer, W. Janssens, and M. Miravitlles Chronic obstructive pulmonary disease Lancet 379 2012 1341 1351
21. G.E. Silva, D.L. Sherrill, S. Guerra, and R.A. Barbee Asthma as a risk factor for COPD in a longitudinal study Chest 126 2004 59 65 (Pubitemid 38943118)
22. J.H. Lee, T. Haselkorn, L. Borish, L. Rasouliyan, B.E. Chipps, and S.E. Wenzel Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma Chest 132 2007 1882 1889
23. R. De Marco, S. Accordini, I. Cerveri, A. Corsico, J.M. Antó, and N. Künzli Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm Am J Respir Crit Care Med 175 2007 32 39 (Pubitemid 46105306)
24. A. Papi, M. Romagnoli, S. Baraldo, F. Braccioni, I. Guzzinati, and M. Saetta Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease Am J Respir Crit Care Med 162 2000 1773 1777
25. Y. Kitaguchi, Y. Komatsu, K. Fujimoto, M. Hanaoka, and K. Kubo Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma Int J Chron Obst Respir Dis 7 2012 283 289
26. H.A.M. Kerstjens, S.E. Overbeek, J.P. Schouten, P.L.P. Brand, and D.S. Postma Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled conticosteroid treatment Eur Respir J 6 1993 868 876 (Pubitemid 23193024)
27. R. Leigh, M.M.M. Pizzichini, M.M. Morris, F. Maltais, F.E. Hargreave, E. Pizzichini, and C.O.P.D. Stable predicting benefit from high-dose inhaled corticosteroid treatment Eur Respir J 27 2006 964 971 (Pubitemid 44911110)
28. C.E. Brightling, S. McKenna, B. Hardagon, S. Birring, R. Green, and R. Siva Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pumonary disease Thorax 60 2005 193 198 (Pubitemid 40380276)
29. D.E. O'Donnell, S. Aaron, J. Bourbeau, P. Hernandez, D.D. Marciniuk, and M. Balter Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update Can Respir J 14 Suppl. B 2007 5B 32B (Pubitemid 350090390)
30. A. Nagai, H. Aizawa, K. Aoshiba, K. Asano, K. Hirata, and M. Ichinose Guidelines for the diagnosis and treatment of COPD 3rd ed. 2009 The Japanese Respiratory Society. Medical Review Co. Ltd Tokyo,Japan
31. M. Miravitlles, J.J. Soler-Cataluña, M. Calle, J. Molina, P. Almagro, and J.A. Quintano Spanish COPD guidelines (GesEPOC). Pharmacological treatment of stable COPD Arch Bronconeumol 48 2012 247 257
32. J.J. Soler-Cataluña, B. Cosío, J.L. Izquierdo, J.L. López-Campos, J.M. Marín, and R. Agüero Consensus document on the overlap phenotype COPD-asthma in COPD Arch Bronconeumol 48 2012 331 337
33. B. Waschki, A. Kirsten, O. Holz, K.C. Müller, T. Meyer, and H. Watz Physical activity is the strongest predictor of all-cause mortality in patients with COPD Chest 140 2011 331 342
34. F. García-Río, B. Rojo, R. Casitas, V. Lores, R. Madero, and D. Romero Prognostic value of the objective measurement of daily physical activity in patients with COPD Chest 142 2012 338 346
35. P. Kauppi, H. Kupiainen, A. Lindqvist, L. Tammilehto, M. Kilpeläinen, and Kinnula Vl Overlap syndrome of asthma and COPD predicts low quality of life J Asthma 48 2011 279 285
36. A. Domingo-Salvany, R. Lamarca, M. Ferrer, J. Garcia-Aymerich, J. Alonso, and M. Félez Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 166 2002 680 685 (Pubitemid 34971850)
37. M.P.M.H. Rutten-van Mölken, J.B. Oostenbrink, D.P. Tashkin, D. Burkhart, and B.U. Monz Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest 130 2006 1117 1128 (Pubitemid 44583743)
38. K. Naberan, A. Azpeitia, J. Cantoni, and M. Miravitlles Impairment in quality of life in women with chronic obstructive pulmonary disease Respir Med 106 2012 367 373
39. M. Miravitlles, K. Naberan, J. Cantoni, and A. Azpeitia Socioeconomic status and health-related quality of life of patients with COPD Respiration 82 2011 402 408
40. M. Miravitlles, I. Izquierdo, A. Herrejon, J.V. Torres, E. Baró, and J. Borja COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study Respir Med 105 2011 740 747
41. C.E. Brightling, W. Monteiro, R. Ward, D. Parker, M.D.L. Morgan, and A.J. Wardlaw Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease Lancet 356 2000 1480 1485
42. M. Miravitlles, J.J. Soler-Cataluña, M. Calle, and J. Soriano Treatment of COPD by clinical phenotypes. Putting old evidence into clinical practice Eur Respir J 2012 10.1183/09031936.00118912